Blood Stream Infection Testing-Global Market Status and Trend Report 2013-2023
SKU ID :MI-11931724 | Published Date: 04-Apr-2018 | No. of pages: 147Description
TOC
Table of Contents
Chapter 1 Overview of Blood Stream Infection Testing
1.1 Definition of Blood Stream Infection Testing in This Report
1.2 Commercial Types of Blood Stream Infection Testing
1.2.1 Instruments
1.2.2 Consumables
1.3 Downstream Application of Blood Stream Infection Testing
1.3.1 Hospitals
1.3.2 Diagnostics Clinical Laboratories
1.3.3 Other
1.4 Development History of Blood Stream Infection Testing
1.5 Market Status and Trend of Blood Stream Infection Testing 2013-2023
1.5.1 Global Blood Stream Infection Testing Market Status and Trend 2013-2023
1.5.2 Regional Blood Stream Infection Testing Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Blood Stream Infection Testing 2013-2017
2.2 Production Market of Blood Stream Infection Testing by Regions
2.2.1 Production Volume of Blood Stream Infection Testing by Regions
2.2.2 Production Value of Blood Stream Infection Testing by Regions
2.3 Demand Market of Blood Stream Infection Testing by Regions
2.4 Production and Demand Status of Blood Stream Infection Testing by Regions
2.4.1 Production and Demand Status of Blood Stream Infection Testing by Regions 2013-2017
2.4.2 Import and Export Status of Blood Stream Infection Testing by Regions 2013-2017
Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Blood Stream Infection Testing by Types
3.2 Production Value of Blood Stream Infection Testing by Types
3.3 Market Forecast of Blood Stream Infection Testing by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Blood Stream Infection Testing by Downstream Industry
4.2 Market Forecast of Blood Stream Infection Testing by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Blood Stream Infection Testing
5.1 Global Economy Situation and Trend Overview
5.2 Blood Stream Infection Testing Downstream Industry Situation and Trend Overview
Chapter 6 Blood Stream Infection Testing Market Competition Status by Major Manufacturers
6.1 Production Volume of Blood Stream Infection Testing by Major Manufacturers
6.2 Production Value of Blood Stream Infection Testing by Major Manufacturers
6.3 Basic Information of Blood Stream Infection Testing by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Blood Stream Infection Testing Major Manufacturer
6.3.2 Employees and Revenue Level of Blood Stream Infection Testing Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Blood Stream Infection Testing Major Manufacturers Introduction and Market Data
7.1 BD Medical
7.1.1 Company profile
7.1.2 Representative Blood Stream Infection Testing Product
7.1.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BD Medical
7.2 Thermo Fisher Scientific
7.2.1 Company profile
7.2.2 Representative Blood Stream Infection Testing Product
7.2.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
7.3 BioMerieux
7.3.1 Company profile
7.3.2 Representative Blood Stream Infection Testing Product
7.3.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BioMerieux
7.4 Cepheid
7.4.1 Company profile
7.4.2 Representative Blood Stream Infection Testing Product
7.4.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Cepheid
7.5 Roche Diagnostics
7.5.1 Company profile
7.5.2 Representative Blood Stream Infection Testing Product
7.5.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.6 Abbott Molecular
7.6.1 Company profile
7.6.2 Representative Blood Stream Infection Testing Product
7.6.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Abbott Molecular
7.7 Beckman Coulter
7.7.1 Company profile
7.7.2 Representative Blood Stream Infection Testing Product
7.7.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.8 Siemens
7.8.1 Company profile
7.8.2 Representative Blood Stream Infection Testing Product
7.8.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Siemens
7.9 Alere
7.9.1 Company profile
7.9.2 Representative Blood Stream Infection Testing Product
7.9.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Alere
7.10 Bruker
7.10.1 Company profile
7.10.2 Representative Blood Stream Infection Testing Product
7.10.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Bruker
7.11 AB Sciex
7.11.1 Company profile
7.11.2 Representative Blood Stream Infection Testing Product
7.11.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AB Sciex
7.12 Nanosphere
7.12.1 Company profile
7.12.2 Representative Blood Stream Infection Testing Product
7.12.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Nanosphere
7.13 Eurogentec
7.13.1 Company profile
7.13.2 Representative Blood Stream Infection Testing Product
7.13.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Eurogentec
7.14 AdvanDX
7.14.1 Company profile
7.14.2 Representative Blood Stream Infection Testing Product
7.14.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AdvanDX
7.15 Dade Behring
7.15.1 Company profile
7.15.2 Representative Blood Stream Infection Testing Product
7.15.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Dade Behring
Chapter 8 Upstream and Downstream Market Analysis of Blood Stream Infection Testing
8.1 Industry Chain of Blood Stream Infection Testing
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Blood Stream Infection Testing
9.1 Cost Structure Analysis of Blood Stream Infection Testing
9.2 Raw Materials Cost Analysis of Blood Stream Infection Testing
9.3 Labor Cost Analysis of Blood Stream Infection Testing
9.4 Manufacturing Expenses Analysis of Blood Stream Infection Testing
Chapter 10 Marketing Status Analysis of Blood Stream Infection Testing
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
Tables & Figures
List of Tables
Table Advantage and Disadvantage of Instruments
Table Advantage and Disadvantage of Consumables
Table Production Volume of Blood Stream Infection Testing by Regions 2013-2017
Table Production Value of Blood Stream Infection Testing by Regions 2013-2017
Table Demand Volume of Blood Stream Infection Testing by Regions 2013-2017
Table Production and Demand Status of Blood Stream Infection Testing in Region One 2013-2017
Table Production and Demand Status of Blood Stream Infection Testing in Region Two 2013-2017
Table Production and Demand Status of Blood Stream Infection Testing in Region Three 2013-2017
Table Production and Demand Status of Blood Stream Infection Testing in Region Four 2013-2017
Table Import Volume of Blood Stream Infection Testing by Regions 2013-2017
Table Export Volume of Blood Stream Infection Testing by Regions 2013-2017
Table Production Volume of Blood Stream Infection Testing by Types 2013-2017
Table Production Value of Blood Stream Infection Testing by Types 2013-2017
Table Production Volume Forecast of Blood Stream Infection Testing by Types 2018-2023
Table Production Value Forecast of Blood Stream Infection Testing by Types 2018-2023
Table Demand Volume of Blood Stream Infection Testing by Downstream Industry 2013-2017
Table Demand Volume Forecast of Blood Stream Infection Testing by Downstream Industry 2018-2023
Table Production Volume of Blood Stream Infection Testing by Major Manufacturers 2013-2017
Table Production Value of Blood Stream Infection Testing by Major Manufacturers 2013-2017
Table Headquarters Location and Established Time of Blood Stream Infection Testing Major Manufacturer
Table Employees and Revenue Level of Blood Stream Infection Testing Major Manufacturer
Table Representative Blood Stream Infection Testing Product One of BD Medical
Table Representative Blood Stream Infection Testing Product Two of BD Medical
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BD Medical 2013-2017
Table Representative Blood Stream Infection Testing Product One of Thermo Fisher Scientific
Table Representative Blood Stream Infection Testing Product Two of Thermo Fisher Scientific
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific 2013-2017
Table Representative Blood Stream Infection Testing Product One of BioMerieux
Table Representative Blood Stream Infection Testing Product Two of BioMerieux
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BioMerieux 2013-2017
Table Representative Blood Stream Infection Testing Product One of Cepheid
Table Representative Blood Stream Infection Testing Product Two of Cepheid
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Cepheid 2013-2017
Table Representative Blood Stream Infection Testing Product One of Roche Diagnostics
Table Representative Blood Stream Infection Testing Product Two of Roche Diagnostics
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Roche Diagnostics 2013-2017
Table Representative Blood Stream Infection Testing Product One of Abbott Molecular
Table Representative Blood Stream Infection Testing Product Two of Abbott Molecular
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Abbott Molecular 2013-2017
Table Representative Blood Stream Infection Testing Product One of Beckman Coulter
Table Representative Blood Stream Infection Testing Product Two of Beckman Coulter
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Beckman Coulter 2013-2017
Table Representative Blood Stream Infection Testing Product One of Siemens
Table Representative Blood Stream Infection Testing Product Two of Siemens
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Siemens 2013-2017
Table Representative Blood Stream Infection Testing Product One of Alere
Table Representative Blood Stream Infection Testing Product Two of Alere
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Alere 2013-2017
Table Representative Blood Stream Infection Testing Product One of Bruker
Table Representative Blood Stream Infection Testing Product Two of Bruker
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Bruker 2013-2017
Table Representative Blood Stream Infection Testing Product One of AB Sciex
Table Representative Blood Stream Infection Testing Product Two of AB Sciex
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AB Sciex 2013-2017
Table Representative Blood Stream Infection Testing Product One of Nanosphere
Table Representative Blood Stream Infection Testing Product Two of Nanosphere
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Nanosphere 2013-2017
Table Representative Blood Stream Infection Testing Product One of Eurogentec
Table Representative Blood Stream Infection Testing Product Two of Eurogentec
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Eurogentec 2013-2017
Table Representative Blood Stream Infection Testing Product One of AdvanDX
Table Representative Blood Stream Infection Testing Product Two of AdvanDX
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AdvanDX 2013-2017
Table Representative Blood Stream Infection Testing Product One of Dade Behring
Table Representative Blood Stream Infection Testing Product Two of Dade Behring
Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Dade Behring 2013-2017
Companies
- PRICE
-
$2980$4480